Hackman Jeffrey S. bought FENC
March 31, 2026 · Form 4 insider transaction
Hackman Jeffrey S. bought 16,695 shares of Fennec Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,695
Price
$0.00
Total value
N/A
InsiderHackman Jeffrey S.
RoleOfficer, Director
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after45,405
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents settlement of PSUs that vested on March 31, 2026.